SCHEMBL8350419

SCHEMBL8350419

CC(C)(C)OC(=O)N1CCC(C#N)(c2ccc3ccccc3c2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.59
JAK2 O60674 1/20 0.44
JAK1 P23458 1/20 0.44
OPRL1 P41146 1/20 0.44
TSHR P16473 2/20 0.43
ALOX15 P16050 1/20 0.43
ATM Q13315 1/20 0.43
TACR1 P25103 1/20 0.42
CYP11B2 P19099 1/20 0.42
KMT2A Q03164 1/20 0.41
F11 P03951 1/20 0.41
EGLN2 Q96KS0 1/20 0.41
GPR119 Q8TDV5 1/20 0.40
ACKR3 P25106 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2529921 0.86 CA12 (0.54) OPRM1TSHRALOX15ATMTACR1
SCHEMBL3249093 0.83 KMT2A (0.63) JAK2JAK1TSHRALOX15ATM
SCHEMBL31158311 0.83 KMT2A (0.63) JAK2JAK1TSHRALOX15ATM
SCHEMBL4657276 0.83 OPRM1 (0.58) OPRM1OPRL1TSHRALOX15ATM
SCHEMBL27225781 0.83 JAK2 (0.47) JAK2JAK1TSHRALOX15ATM
SCHEMBL1103996 0.82 ALDH1A1 (0.51) JAK2JAK1TSHRKMT2AGPR119
SCHEMBL22509312 0.82 OPRM1 (0.55) OPRM1JAK2JAK1TSHRALOX15
SCHEMBL4406762 0.82 CYP2D6 (0.47) JAK2JAK1TSHRALOX15ATM
SCHEMBL2701636 0.82 GPR119 (0.45) JAK2JAK1TSHRALOX15ATM
SCHEMBL2573823 0.82 STS (0.47) JAK2JAK1TSHRALOX15ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5861416-A TREATMENT OF ASTHMA OR COUGH MERRELL PHARMACEUTICALS INC. (US) 1999-01-19 US disclosed
US-5824690-A TREATING ASTHMA, COUGH HOECHST MARION ROUSSEL INC. (US) 1998-10-20 US disclosed
EP-0696280-B1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL PHARMA INC (US) 1997-09-24 EP disclosed
US-5661160-A ADMINISTERING AN ANTITUSSIVE AGENT FOR TREATING COUGH; TACHYKININ ANTAGONISM, SUBSTANCE P AND NEUROKININ A ANTAGONISM MERRELL PHARMACEUTICALS INC. (US) 1997-08-26 US disclosed
US-5648366-A TACHYKININ ANTAGONISTS USEFUL IN TREATING ASTHMA MERRELL PHARMACEUTICALS INC. (US) 1997-07-15 US disclosed
US-5635510-A TACHYKININ (ESPECIALLY SUBSTANCE P AND NEUROKININ A) ANTAGONISTS; ANTIINFLAMMATORY AGENTS, ANALGESICS; NERVOUS SYSTEM DISORDERS; BRONCHODILATOR AGENTS MERRELL PHARMACEUTICALS INC. (US) 1997-06-03 US disclosed
EP-0696280-A1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL DOW PHARMA (US) 1996-02-14 EP disclosed
WO-1994026735-A1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL DOW PHARMACEUTICALS INC. (US) 1994-11-24 WO disclosed